Authors:
Caliendo, G
Fiorino, F
Grieco, P
Perissutti, E
Santagada, V
Severino, B
Bruni, G
Romeo, MR
Citation: G. Caliendo et al., Synthesis of new 1,2,3-benzotriazin-4-one-arylpiperazine derivatives as 5-HT1A serotonin receptor ligands, BIO MED CH, 8(3), 2000, pp. 533-538
Authors:
Caliendo, G
Fiorino, F
Grieco, P
Perissutti, E
Santagada, V
Albrizio, S
Spadola, L
Bruni, G
Romeo, MR
Citation: G. Caliendo et al., Synthesis and binding affinities for 5-HT1A, 5-HT2A and 5-HT2C receptors of a series of 1-and 2-(4-arylpiperazinylalkyl)-4-(benzoyl)-1,2,3-triazole derivatives, EUR J MED C, 34(9), 1999, pp. 719-727
Authors:
Iakovou, K
Kazanis, M
Vavayannis, A
Bruni, G
Romeo, MR
Massarelli, P
Teramoto, S
Fujiki, H
Mori, T
Citation: K. Iakovou et al., Synthesis of oxypropanolamine derivatives of 3,4-dihydro-2H-1,4-benzoxazine, beta-adrenergic affinity, inotropic, chronotropic and coronary vasodilating activities, EUR J MED C, 34(11), 1999, pp. 903-917
Authors:
Cappelli, A
Anzini, M
Vomero, S
Canullo, L
Mennuni, L
Makovec, F
Doucet, E
Hamon, M
Menziani, MC
De Benedetti, PG
Bruni, G
Romeo, MR
Giorgi, G
Donati, A
Citation: A. Cappelli et al., Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy ofarylpiperazine derivatives at the central 5-HT3 receptors, J MED CHEM, 42(9), 1999, pp. 1556-1575